Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

Dynasil Corp. of America

Jul 2011
Dynasil Corp. of America, based in Watertown, Mass., has incorporated a business unit, Dynasil Biomedical Corp., in Rochester, Minn., to pursue opportunities in the field. Daniel Ericson has joined the new unit as its scientific leader with responsibility for research and development. The unit purchased for $300,000 Ericson’s rights to six biomedical technologies invented or co-invented by him, as well as certain rights to royalties and milestone payments if the technologies are successfully developed. Several of the technologies are jointly owned with the Mayo Clinic, where Ericson previously worked. All in the early stage of development, the inventions include a tuberculosis test, a tissue sealant and diagnostic tests using handheld optical detection systems. The unit will collaborate with Dynasil’s RMD Research organization and its RMD Instruments business.

Americasbiomedical technologiesBiophotonicsblood coagulationBusinesscardiovascular risksDaniel EricsonDynasil Biomedical Corp.Dynasil Corporation of AmericahemophiliaimagingMassachusettsMayo ClinicMinnesotaoptical detection systemspoint-of-care diagnosticsRapidScanRMD InstrumentsRMD Researchtissue sealanttuberculosis test

Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media
x Subscribe to BioPhotonics magazine - FREE!